BR Biopharma, Inc. (NASDAQ:BRBI) Sees Large Increase in Short Interest

BR Biopharma, Inc. (NASDAQ:BRBI) saw a large increase in short interest in October. As of October 30th, there was short interest totaling 13,657 shares, an increase of 1,264.3% from the October 15th total of 1,001 shares. Approximately 0.1% of the company’s shares are sold short. Based on an average trading volume of 6,646 shares, the days-to-cover ratio is presently 2.1 days.

Analyst Ratings Changes

A number of analysts have recently weighed in on BRBI shares. Citigroup lowered BR Biopharma from a “buy” rating to a “hold” rating in a research report on Tuesday, October 27th. Weiss Ratings upgraded shares of BR Biopharma from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday, October 2nd. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce”.

BR Biopharma Trading Up 4.7%

Shares of NASDAQ BRBI traded up $0.34 during midday trading on Thursday, reaching $7.65. 327 shares of the company were exchanged, compared to its average volume of 5,042. The stock has a market cap of $90.35 million, a P/E ratio of 95.62 and a beta of 0.43. The stock has a fifty day simple moving average of $11.41 and a 200 day simple moving average of $12.51. BR Biopharma has a 1 year low of $6.87 and a 1 year high of $16.61.

BR Biopharma (NASDAQ:BRBI) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $0.05 earnings per share for the quarter. The company had revenue of $23.80 million for the quarter.

BR Biopharma Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 4th. Investors of record on Monday, November 16th will be paid a $0.0879 dividend. This represents a $0.35 annualized dividend and a dividend yield of 4.6%. This is a negative change from BR Biopharma’s previous quarterly dividend of $0.1415. The ex-dividend date is Monday, November 16th. BR Biopharma’s dividend payout ratio (DPR) is 525.00%.

BR Biopharma Company Profile

BRBI BR Partners S.A., through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners S.A. is based in S?o Paulo, Brazil.